[The level of Bcl-2 and Fas expression in thymoma tissue from patients with myasthenia gravis].
Zhonghua Jie He He Hu Xi Za Zhi
; 29(4): 240-2, 2006 Apr.
Article
in Zh
| MEDLINE
| ID: mdl-16750039
ABSTRACT
OBJECTIVE:
To evaluate the clinical significance of expression levels of apoptosis-associated genes, bcl-2 and Fas in thymoma tissue from patients with myasthenia gravis.METHODS:
The study included 25 patients who underwent maximal thymectomy because of concurrent thymoma and myasthenia gravis. Clinical staging (Osserman classification) showed stage I in 6, IIA in 3, IIB in 13 and III in 3 cases. According to the WHO classification of thymomas (1999), 5, 3, 7, 7, and 3 patients had type A, AB, B1, B2, and B3, respectively, and no patient had type C. As a control group, the normal thymic tissue from 25 patients with congenital heart diseases was studied. The expression level of Bcl-2 and Fas in the tissue of thymoma and normal thymus was detected by immunohistochemistry.RESULTS:
Bcl-2 and Fas expressions were significantly higher in thymomas compared with normal thymus by Radit analyses (U = 2.645, P < 0.05 and U = 3.200, P < 0.05, respectively). The expression level of Bcl-2 and Fas showed no relation to the course of the disease, age, Osserman classification and sex.CONCLUSION:
The result suggests that the two apoptosis-associated factors, Bcl-2 and Fas, may play important roles in the pathogenesis of thymoma concurrent with myasthenia gravis.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thymoma
/
Thymus Neoplasms
/
Fas Receptor
/
Proto-Oncogene Proteins c-bcl-2
/
Myasthenia Gravis
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
Zh
Journal:
Zhonghua Jie He He Hu Xi Za Zhi
Year:
2006
Document type:
Article
Affiliation country: